These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 19781297
1. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B. Gu XB, Yang XJ, Wang D, Hua Z, Xu YQ, Lu ZH. Chin Med J (Engl); 2009 Sep 20; 122(18):2129-32. PubMed ID: 19781297 [Abstract] [Full Text] [Related]
2. [Relations between ALT level and count of HBV special CTL and non-specific CTL in patients with chronic hepatitis B]. Gu XB, Yang XJ, Wang D, Hua Z, Wu HY, Xu YQ, Lu ZH. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct 20; 23(5):343-5. PubMed ID: 20387481 [Abstract] [Full Text] [Related]
3. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B]. Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, Moon YM. Taehan Kan Hakhoe Chi; 2002 Jun 20; 8(2):139-48. PubMed ID: 12499799 [Abstract] [Full Text] [Related]
4. PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection. Xibing G, Xiaojuan Y, Juanhua W. J Viral Hepat; 2013 Apr 20; 20(4):e1-2. PubMed ID: 23490376 [Abstract] [Full Text] [Related]
5. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B]. Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY. Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 20; 11(3):173-5. PubMed ID: 12681068 [Abstract] [Full Text] [Related]
6. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B]. Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M. Taehan Kan Hakhoe Chi; 2003 Dec 20; 9(4):284-92. PubMed ID: 14695695 [Abstract] [Full Text] [Related]
7. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients]. Li J, Han YP, Liu B, Liu Y, Chen N, Dong L, Yan YD, Jiang LF, Huang ZH. Zhonghua Gan Zang Bing Za Zhi; 2011 Jan 20; 19(1):38-43. PubMed ID: 21272457 [Abstract] [Full Text] [Related]
8. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B]. Xu QH, Shu X, Chen LB, Huang HH, Zhang K, Li G. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec 20; 22(6):422-4. PubMed ID: 19544633 [Abstract] [Full Text] [Related]
9. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks]. He H, Xu ZN, Cai DC, Nai N, Ling N, Zeng WQ, Shi XF, Zhao YR, Zhou Z, Zhang DZ. Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 20; 17(4):271-4. PubMed ID: 19403025 [Abstract] [Full Text] [Related]
10. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients]. Rüzgar M, Cetin Akhan S, Vahaboğlu H. Mikrobiyol Bul; 2008 Apr 20; 42(2):283-91. PubMed ID: 18697426 [Abstract] [Full Text] [Related]
11. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]. Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A. Mikrobiyol Bul; 2007 Jan 20; 41(1):87-93. PubMed ID: 17427556 [Abstract] [Full Text] [Related]
12. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B. Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Gastroenterology; 2009 Feb 20; 136(2):505-12. PubMed ID: 19101558 [Abstract] [Full Text] [Related]
13. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy. Yuen MF, Fung J, Seto WK, Wong DK, Yuen JC, Lai CL. Antivir Ther; 2009 Feb 20; 14(5):679-85. PubMed ID: 19704171 [Abstract] [Full Text] [Related]
14. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection. Madan K, Batra Y, Jha JK, Kumar S, Kalra N, Paul SB, Singh R, Duttagupta S, Panda SK, Acharya SK. Trop Gastroenterol; 2008 Feb 20; 29(2):84-90. PubMed ID: 18972767 [Abstract] [Full Text] [Related]
15. [Effect of kurarinol on peripheral blood CTL surface PD-1 expression of patients with chronic hepatitis B]. Zhu YF, Gu XB, Yang XJ, Hua Z, Lu ZH, Zang B, Wu HY, Jiang YM, Chen HK, Pei H, Xu YQ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec 20; 26(6):446-9. PubMed ID: 23627026 [Abstract] [Full Text] [Related]
16. [Clinical significance of intrahepatic hepatitis B core antigen (+) in patients with chronic hepatitis B]. Pan HY, Zhang YL, Chen CR, Wang J, Li BR, Lu DR, Lou GQ, Shi JP. Zhonghua Gan Zang Bing Za Zhi; 2007 Aug 20; 15(8):582-4. PubMed ID: 17711626 [Abstract] [Full Text] [Related]
17. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B. Oketani M, Oketani K, Xiaohong C, Arima T. J Med Virol; 1999 Aug 20; 58(4):332-7. PubMed ID: 10421398 [Abstract] [Full Text] [Related]
18. A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine. Ide T, Kumashiro R, Koga Y, Tanaka E, Hino T, Hisamochi A, Murashima S, Ogata K, Tanaka K, Kuwahara R, Sata M. Am J Gastroenterol; 2003 Sep 20; 98(9):2048-51. PubMed ID: 14499786 [Abstract] [Full Text] [Related]
19. Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia. Bozkaya H, Yurdaydin C, Idilman R, Tüzün A, Cinar K, Erkan O, Bozdayi AM, Erden E, Uzun Y, Cetinkaya H, Uzunalimoglu O. Antivir Ther; 2005 Sep 20; 10(2):319-25. PubMed ID: 15865226 [Abstract] [Full Text] [Related]
20. [Investigation of the relationship between serum nitric oxide levels, HBV-DNA and ALT levels in chronic hepatitis B patients]. Sener AG, Kirdar S, Serter M, Afşar I, Demir EM, Ceylan C, Aydin N. Mikrobiyol Bul; 2009 Jan 20; 43(1):83-9. PubMed ID: 19334384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]